PHAXIAM Therapeutics S.A.

Delisted

CIK 1624422fmd_11MVWT1HSSYES82Y6QDPX6ZQX6Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2015 to Jun 30, 2023, 14 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.